Literature DB >> 7632094

Association between human parvovirus B19 infection and arthritis.

P Cassinotti1, S Bas, G Siegl, T L Vischer.   

Abstract

OBJECTIVE: To gain information concerning the association between parvovirus B19 infection and arthritis.
METHODS: Blood or synovial fluid, or both, from a total of 77 adult patients with various arthropathies (rheumatoid arthritis 13; mechanical arthropathies 11; crystal induced arthritis 13; idiopathic mono/oligoarthritis 25; suspicion of viral arthritis 15) were tested for the presence of the viral genome and anti-B19 antibodies. B19 DNA in blood and synovial fluid was investigated by nested polymerase chain reaction, and anti-B19 IgM and IgG antibodies were detected in blood by enzyme immunoassay.
RESULTS: A recent parvovirus infection was documented by the presence of anti-B19 IgM antibodies in the blood of 13 patients. B19 DNA, together with anti-B19 IgM and IgG antibodies, were detected in the blood of seven patients who had an acute transient arthritis, putatively of viral origin. Viral DNA was detected in a synovial fluid sample and in the blood of one patient with monoarthritis who had an anti-B19 IgG response only.
CONCLUSIONS: The prevalence of anti-B19 IgG antibody in these patients with various forms of arthritis (63%) was within the same range as that in the general population (blood donors). However, for the patients with clinical suspicion of viral arthritis, the increased seroprevalence of anti-B19 IgM and the presence of the B19 genome point to an association between human parvovirus infections and acute forms of arthritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632094      PMCID: PMC1009910          DOI: 10.1136/ard.54.6.498

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  The prevalence of antibody to human parvovirus B19 in England and Wales.

Authors:  B J Cohen; M M Buckley
Journal:  J Med Microbiol       Date:  1988-02       Impact factor: 2.472

2.  Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis.

Authors:  R O Shade; M C Blundell; S F Cotmore; P Tattersall; C R Astell
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

3.  Human parvovirus B19 DNA in synovial fluid.

Authors:  B A Dijkmans; A M van Elsacker-Niele; M M Salimans; G A van Albada-Kuipers; E de Vries; H T Weiland
Journal:  Arthritis Rheum       Date:  1988-02

4.  Detection of parvovirus in a patient with "reactive arthritis" by in situ hybridization.

Authors:  R Kandolf; P Kirschner; P H Hofschneider; T L Vischer
Journal:  Clin Rheumatol       Date:  1989-09       Impact factor: 2.980

5.  Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Authors:  G J Kurtzman; B J Cohen; A M Field; R Oseas; R M Blaese; N S Young
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

6.  Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

Authors:  B J Cohen; P P Mortimer; M S Pereira
Journal:  J Hyg (Lond)       Date:  1983-08

7.  Human parvovirus-associated arthritis: a clinical and laboratory description.

Authors:  D M Reid; T M Reid; T Brown; J A Rennie; C J Eastmond
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

8.  Human parvovirus arthropathy.

Authors:  D G White; A D Woolf; P P Mortimer; B J Cohen; D R Blake; P A Bacon
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

9.  Experimental parvoviral infection in humans.

Authors:  M J Anderson; P G Higgins; L R Davis; J S Willman; S E Jones; I M Kidd; J R Pattison; D A Tyrrell
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

10.  Human parvovirus B19-associated arthritis in children.

Authors:  J J Nocton; L C Miller; L B Tucker; J G Schaller
Journal:  J Pediatr       Date:  1993-02       Impact factor: 4.406

View more
  4 in total

Review 1.  [PCR-based detection of pathogens in clinical rheumatology].

Authors:  B Ehrenstein; U Reischl
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

2.  Parvovirus B19 infection in sickle cell disease: An analysis from the Centers for Disease Control haemoglobinopathy blood surveillance project.

Authors:  Suvankar Majumdar; Christopher J Bean; Christine De Staercke; James Bost; Robert Nickel; Thomas Coates; Andrew Campbell; Alexis Thompson
Journal:  Transfus Med       Date:  2020-03-04       Impact factor: 2.057

3.  Seroprevalence of parvovirus B19 antibodies and evidence of viremia among Nigerian patients with sickle cell anemia.

Authors:  Bamidele Abiodun Iwalokun; Senapon Olusola Iwalokun; Semande Olufunmilayo Hodonu
Journal:  J Biomed Res       Date:  2013-06-15

4.  Persistence of human parvovirus B19 in tissues from adult individuals: a comparison with serostatus and its clinical utility.

Authors:  R Aravindh; Uma Nahar Saikia; Baijayantimala Mishra; Vandana Kumari; Subhabrata Sarkar; Mirnalini Sharma; Radha Kanta Ratho; Kusum Joshi
Journal:  Arch Virol       Date:  2014-04-30       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.